Heart Disease Number ONE Killer of Women

Translate to Spanish or other 102 languages!

Despite increases in awareness over the past decades, only about half (56%) of women recognize that heart disease is their number 1 killer. Image for illustration purposes
Despite increases in awareness over the past decades, only about half (56%) of women recognize that heart disease is their number 1 killer. Image for illustration purposes

Mega Doctor News

- Advertisement -

By Texas Tech University Health Sciences Center El Paso

Newswise — How does heart disease affect women?

Despite increases in awareness over the past decades, only about half (56%) of women recognize that heart disease is their number 1 killer.

- Advertisement -

Hormonal changes that occur during menopause can bring increased cardiovascular risk in the form of higher blood pressure and cholesterol levels.

Some facts about women and heart disease:

Heart disease is the leading cause of death for women in the United States, killing 314,186 women in 2020—or about 1 in every 5 female deaths.

Heart disease is the leading cause of death for African American and white women in the United States. For Hispanic women, heart disease is second only to cancer as a cause of death.

  • About 1 in 16 women age 20 and older (6.2%) have coronary heart disease, the most common type of heart disease:
    • About 1 in 16 white women (6.1%), black women (6.5%), and Hispanic women (6%)
    • About 1 in 30 Asian women (3.2%)
- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -